Home/Filings/4/0001209191-18-019568
4//SEC Filing

Krell Elizabeth D 4

Accession 0001209191-18-019568

CIK 0001323885other

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 4:34 PM ET

Size

8.8 KB

Accession

0001209191-18-019568

Insider Transaction Report

Form 4
Period: 2018-03-12
Transactions
  • Exercise/Conversion

    Common Stock

    2018-03-12$14.17/sh+10,000$141,70029,967 total
  • Sale

    Common Stock

    2018-03-13$20.00/sh10,000$200,00019,967 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-03-1210,0000 total
    Exercise: $14.17From: 2012-05-18Exp: 2021-05-18Common Stock (10,000 underlying)
Footnotes (2)
  • [F1]This transaction was executed in multiple trades at prices ranging from $19.88 to $20.15 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]These options were granted on May 18, 2011 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant.

Issuer

AtriCure, Inc.

CIK 0001323885

Entity typeother

Related Parties

1
  • filerCIK 0001367742

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:34 PM ET
Size
8.8 KB